MobiHealth News September 22, 2021
The Wall Street Journal reports that the work on the feature could be born out of collaborations with UCLA and Biogen.
Apple is looking to use digital biomarkers to help detect depression and early-stage cognitive decline, according to a new report out of The Wall Street Journal.
The end goal, according to the Journal, is to create a new Apple feature that would tell users if there was a potential mental illness. Data collected regarding a users’ mobility, physical activity, sleep pattern could be included in the algorithm.
The report notes that the new effort could be tied to collaborations that the Silicon Valley titan already has established with UCLA researchers and pharma company Biogen.
At the beginning...